UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000007941
Receipt number R000009278
Scientific Title Phase ll trial of TS-1 + CDDP + Trastuzumab (SPT) - 3 weekly schedule in HER2-positive advanced gastric cancer without measurable metastatic lesion (HERBIS-1B) (OGSG 1202)
Date of disclosure of the study information 2012/05/14
Last modified on 2020/01/22 22:19:14

No. Disposal Last modified on Item of update
1 Insert 2012/05/13 23:16:47
2 Update 2012/06/24 22:22:33 Public title
Public title
3 Update 2012/08/05 22:53:34 Address
4 Update 2013/05/15 21:25:43 Anticipated trial start date
Last follow-up date
5 Update 2013/05/15 21:28:28 Anticipated trial start date
Last follow-up date
6 Update 2014/11/15 14:36:19 Last follow-up date
7 Update 2014/11/15 14:48:48 TEL
Email
TEL
Email
Institutions
8 Update 2015/05/13 23:03:23 Email
9 Update 2015/11/14 00:11:05 Last follow-up date
10 Update 2015/12/14 23:11:05 Institutions
11 Update 2016/05/17 00:21:36 Name of primary person or sponsor
Organization
12 Update 2016/06/19 07:44:08 Recruitment status
13 Update 2016/12/07 20:53:21 Organization
Organization
Organization
Category of Funding Organization
14 Update 2018/04/30 23:45:50 Email
15 Update 2018/05/10 20:31:42 Email
16 Update 2018/11/20 22:19:07 Recruitment status
Last follow-up date
Date analysis concluded
17 Update 2020/01/05 18:27:03 Date of IRB
18 Update 2020/01/05 18:46:59 Date analysis concluded
19 Update 2020/01/05 19:32:43 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
20 Update 2020/01/22 22:19:14 Date of IRB